Financials

Financials — BAWAG Group AG (BG)

BAWAG is a €72bn-asset Austrian bank that has compounded book value and earnings while shrinking its share count — a rare combination in European banking. FY2025 operating income reached €2,216m (+36% YoY), net profit €859.9m (+13%), and return on tangible common equity 26.9% — roughly twice the European bank median. The growth is acquisition-led (Knab €15.9bn book in Nov 2024, Barclays Consumer Bank Europe in Feb 2025, announced Permanent TSB deal Apr 2026), but unit economics — cost-income ratio 36.1%, net interest margin 3.29%, NPL ratio 0.8%, CET1 14.2% — are best-in-class for a developed-market commercial bank. Cash flow is not the right lens for a bank; capital generation and dividend coverage are. The valuation is the live debate: at ~€151.5 the stock trades at ~13.6× trailing earnings and ~3.0× book — cheap on earnings, rich on book — and the rerating from €38 (FY2020 close) to €151 reflects investors discounting a sustained mid-20s RoTCE rather than expecting multiple expansion. The single financial metric that matters most right now is Q2 2026 RoTCE post-Knab/Barclays integration: at or above 25% defends the multiple; a slip toward 20% is consistent with book-multiple compression.

1. Financials in One Page

Reading the bank's vocabulary, once.

• Net Interest Income (NII) — the spread the bank earns from lending vs. funding. Roughly 83% of BAWAG's revenue.
• Pre-Provision Profit (PPP) — operating income minus operating expenses, before loan losses.
• Return on Tangible Common Equity (RoTCE) — net profit divided by tangible book equity. The headline profitability metric for banks.
• Cost-Income Ratio (CIR) — operating expenses ÷ operating income. Lower is better; 35–40% is best-in-class for European retail banks.
• CET1 Ratio — Common Equity Tier 1 capital ÷ risk-weighted assets. Regulatory cushion; 12–14% is typical, BAWAG's management target is at or above 12.25%.
• NPL Ratio — non-performing loans ÷ gross customer loans. Anything under 1% is clean; under 2% is normal.

2. Revenue, Margins, and Earnings Power

For a bank, "revenue" is operating income = NII + net fees + other income. Net interest income is the dominant line and tracks book size × net interest margin (NIM). FY2025 jumped 40% on Knab (closed Nov 2024 — a full year of contribution) and Barclays Consumer Bank Europe (closed Feb 2025 — eleven months of contribution). The underlying organic line is closer to mid-single-digit growth; the rest is M&A.

Mix matters. NII has gone from 71% of operating income in FY2018 to 83% in FY2025. The bank is increasingly a spread machine and decreasingly a fee-driven retail franchise — partly the Knab/Barclays mix shift, partly higher rates, partly reduced trading.

Margin trend — improving, but rate-cycle aware. NIM expanded from 2.03% (FY2020) to 3.29% (FY2025). Q1 2026 hit 3.45%. ECB cuts started in mid-2024 and have continued; loan repricing lags deposit repricing on the way down, so the FY2026 NIM should hold higher than peer for one to two more quarters before normalizing toward 3.0% if rates fall further. Cost-income ratio compressed from 44.3% (FY2020) to 36.1% (FY2025) — pre-provision operating leverage at work, plus disciplined cost integration of the bolt-on deals.

Quarterly trajectory — the recent 3 quarters are the cleanest read of the post-acquisition run-rate. Q1 2025, Q4 2025, and Q1 2026 are the only quarters with both Knab and the Barclays platform consolidated, and they show a mid-20s RoTCE landing zone with NIM expanding into a friendly rate environment.

Earnings power judgment. Improving — but the proof point is a clean Q2 2026 (no acquisition tailwind quarter-on-quarter). PPP growth from €581.6m in FY2020 to €1,416.9m in FY2025 is a 19.5% CAGR; net profit grew 24.7% CAGR over the same window. Both numbers materially benefit from M&A; ex-acquisition organic core revenue growth was guided to roughly 4–5% per year, with the rest coming from rate environment and bolt-on books.

3. Cash Flow and Earnings Quality

For a bank, "free cash flow" is not the right concept. Loan origination is treasury management, not capex. The cash-flow test that matters is whether net profit becomes distributable capital — i.e., does it pass through to dividends, buybacks, and CET1 build, or is it absorbed by reserve growth, deferred-tax shifts, or non-cash valuation gains? In BAWAG's case, almost all of it passes through.

Capital returns since the 2017 IPO total €3.7bn — €2.6bn in dividends and €1.1bn in buybacks — versus cumulative net profit of approximately €4.1bn. That is roughly a 90% lifetime payout ratio, financed entirely from earned capital with no equity issuance since IPO. This is the single most important fact about BAWAG: earnings convert to distributable cash at a rate the European peer set cannot match.

Cash deployment, not cash bleed. Cash and equivalents fell from €17.6bn (end-2024) to €14.1bn (end-2025) — a deliberate redeployment of excess Knab-deposit cash into the loan book (customer loans grew from €45.5bn to €50.7bn). This is not a liquidity warning; LCR is still 204% (regulatory minimum is 100%).

The conservative read is that ~€776m of FY2025 net profit is fully earned — a ~10% haircut to the headline. Even under that reading, RoTCE is mid-20s. Forensic flags exist (auditor change to Deloitte for FY2025, management-overlay smoothing, related-party loans to Management Board members), but none are accounting manipulation; they are presentation choices a careful underwriter notes and discounts.

4. Balance Sheet and Financial Resilience

For a bank the balance sheet is the business. The right tests are capital adequacy, asset quality, liquidity, and funding mix — not net debt / EBITDA.

The €15bn step-up in FY2024 is the Knab acquisition. The further build in FY2025 is the Barclays Consumer Bank Europe consolidation plus organic loan growth. Customer funding (deposits + own issues) of €61.9bn versus customer loans of €50.7bn means BAWAG is structurally over-funded — every loan is more than backed by customer deposits, with the surplus sitting in central-bank reserves and the securities book. This is a deposit-rich franchise.

CET1 dropped from 15.2% (FY2024) to 14.2% (FY2025) as RWAs grew with the loan book; pro-forma for completed deals it sits at 14.6% at year-end and 15.4% in Q1 2026 disclosure. The PTSB acquisition (announced Apr 2026, expected to close 2026 H2 or 2027) would consume roughly 100–150bps of CET1, leaving a 13.0–13.5% landing — comfortably above the 12.25% management threshold and well above ECB SREP requirements (estimated low-12s).

NPL ratio of 0.8% is exceptional — comparable peers run 1.5–3.0%. The 2022 spike in risk costs (€376m, 0.86% ratio) was a single-name City of Linz public-sector receivable write-off (€254m), not a systemic deterioration. FY2025 risk-cost ratio rose modestly to 41 bps reflecting the Barclays consumer book's higher loss profile (a credit-card book has structurally higher charge-offs than a mortgage book) — disclosed and within management's 30–35bps mid-cycle guidance.

5. Returns, Reinvestment, and Capital Allocation

This is where BAWAG separates from European peers. RoTCE has run in the high teens / mid-20s every year since 2018 except for the 2022 Linz-write-off year, while the share count has shrunk by ~22% (from 98.8m at end-2018 to 77.0m at end-2025) — a real per-share compounder.

Per-share value compounding. Tangible book value per share grew from €30.23 (FY2018) to €43.17 (FY2025) — 5.2% CAGR — while shares outstanding fell 22% and dividends totaling €31.81 per share were paid out over the same window. Add it up and shareholders earned tangible book growth + dividends ≈ 13–14% per year on the book metric alone, before any multiple change.

Capital allocation framework, in plain words. Management's stated rule: maintain CET1 at or above 12.25%, target a payout that combines a base dividend (~50% of earnings) and supplemental buyback or special dividend depending on M&A pipeline. In practice, the bank has chosen M&A over buybacks since 2023 (Knab, Barclays, PTSB) — a deliberate redirection of excess capital into deals that, on disclosed metrics, are expected to be high-teens to mid-20s RoTCE accretive in years 2–3. The judgment call: those deal returns require integration execution to materialize. The track record (post-2017 BAWAG P.S.K. integration of Südwestbank, easybank, etc.) is good but not free of multi-year cost programs.

6. Segment and Unit Economics

BAWAG runs two operating segments. Retail & SME is 85% of core revenues; Corporates, Real Estate & Public Sector is 13%; the rest is treasury (Corporate Center). Unit economics are public for Q1 2026 — this is the cleanest data point for what each segment earns on its own equity base.

Where the economics live. Retail & SME drives revenue and RoTCE — mid-30s segment RoTCE at a 4.27% NIM. The Corporates / Real Estate / Public Sector segment is smaller, runs lower NIM (2.0% — senior secured lending compresses spread) and has near-zero risk costs in Q1 2026. Importantly, the Retail segment is deposit-funded — customer deposits of €43.3bn fund just €39.1bn of retail assets, generating a positive funding gap that supports group liquidity.

The geographic mix per the FY2025 Annual Report skews developed-market: Austria, Germany, Switzerland (DACH) plus Netherlands, UK, Ireland, and selective US lending. There is zero direct exposure to Russia, Belarus, Ukraine, or any sanctioned jurisdiction — a point management has emphasized in every recent investor materials cycle to differentiate from Erste/RBI.

7. Valuation and Market Expectations

BAWAG trades at ~13.6× trailing earnings and ~3.0× book at €151.5 — a valuation that looks cheap on earnings and rich on book, and the gap is the entire investment debate. The right framework for a bank is not a single multiple but a P/B vs. RoTCE pair: a 27% RoTCE business mathematically deserves a higher P/B than a 13% RoTCE business, all else equal.

The chart shows a multi-year rerating from sub-1.0× book (FY2020) to ~3.0× book (today). Critically, the rerating tracks the RoTCE trajectory — investors paid more once they believed the mid-20s RoTCE was structural rather than rate-cycle peak.

The simple math. At BVPS of €50.13, every 0.5× of P/B is worth roughly €25 per share. A 1.5× re-derating to peer median (~1.5× P/B) would imply €75. Persistence of the current 25–27% RoTCE supports something close to 2.5–3.0× book, which is where it now trades. The €175 consensus target sits at ~3.5× book and assumes RoTCE persists and PTSB accretes — a tighter assumption than a "fair value at current levels" view. Cheap or expensive depends entirely on whether 25%+ RoTCE is structural or peak-cycle. The bank's own guidance is at or above 20% RoTCE through cycle; the current 27% is above its own guidance.

8. Peer Financial Comparison

The peer set is the six European banks: Erste (Austrian/CEE), KBC (Belgian bancassurer), ING (Dutch global), Commerzbank (German), AIB (Irish), and RBI (Russia-impaired Austrian peer). All FY2025 reported, peer market caps as of 2026-05-04 to 2026-05-06.

The peer gap that matters. BAWAG is the highest-RoTCE bank in the set (27%), and the market has priced it accordingly at 3.0× book — roughly twice the peer-median 1.4× book. The premium is deserved on profitability (KBC at 15% RoTCE earns a 1.74× P/B, so a 27% RoTCE should mathematically be roughly 1.74×(27/15) ≈ 3.1× — almost exactly where BAWAG trades). But the premium leaves zero margin for RoTCE compression. AIB at 22% RoTCE trades at only 1.5× P/B and a single-digit P/E — that is the implicit benchmark if BAWAG's RoTCE were to drop below the mid-20s. The risk is symmetric: hold 25%+ RoTCE and the multiple defends; slip to 20% and it compresses toward AIB-like levels.

9. What to Watch in the Financials

What the financials confirm. BAWAG generates among the highest returns on tangible equity in European banking, runs one of the lowest cost-income ratios, holds a deposit-rich balance sheet with NPL under 1%, and has compounded per-share value through buybacks and disciplined M&A. The earnings-quality concerns are presentational, not substantive — the bank earns what it reports.

What the financials contradict. The "value bank" frame fails at 3× book; the "growth bank" frame fails at single-digit organic growth ex-M&A. The honest read is "high-quality compounder with M&A risk." A more conservative reading of FY2025 net profit (€776m vs. €860m headline) and a sustainable RoTCE in the 22–24% band — rather than the current 27% — implies a fair value 10–15% below the consensus €175 target.

The first financial metric to watch is RoTCE in Q2 2026. It will be the first clean post-acquisition quarter without lapping benefits — a print at or above 25% defends the multiple; a print near 22% is consistent with bear-case multiple compression toward AIB-like levels (~1.5× P/B = ~€75/share).